| Literature DB >> 30017355 |
Saar Vandekeere1, Charlotte Dubois2, Joanna Kalucka2, Mark R Sullivan3, Melissa García-Caballero2, Jermaine Goveia2, Rongyuan Chen4, Frances F Diehl3, Libat Bar-Lev5, Joris Souffreau2, Andreas Pircher2, Saran Kumar5, Stefan Vinckier2, Yoshio Hirabayashi6, Shigeki Furuya7, Luc Schoonjans1, Guy Eelen2, Bart Ghesquière2, Eli Keshet5, Xuri Li8, Matthew G Vander Heiden9, Mieke Dewerchin10, Peter Carmeliet11.
Abstract
The role of phosphoglycerate dehydrogenase (PHGDH), a key enzyme of the serine synthesis pathway (SSP), in endothelial cells (ECs) remains poorly characterized. We report that mouse neonates with EC-specific PHGDH deficiency suffer lethal vascular defects within days of gene inactivation, due to reduced EC proliferation and survival. In addition to nucleotide synthesis impairment, PHGDH knockdown (PHGDHKD) caused oxidative stress, due not only to decreased glutathione and NADPH synthesis but also to mitochondrial dysfunction. Electron transport chain (ETC) enzyme activities were compromised upon PHGDHKD because of insufficient heme production due to cellular serine depletion, not observed in other cell types. As a result of heme depletion, elevated reactive oxygen species levels caused EC demise. Supplementation of hemin in PHGDHKD ECs restored ETC function and rescued the apoptosis and angiogenesis defects. These data argue that ECs die upon PHGDH inhibition, even without external serine deprivation, illustrating an unusual importance of serine synthesis for ECs.Entities:
Keywords: PHGDH; angiogenesis; apoptosis; endothelial cell; heme biosynthesis; mitochondria; pyrimidine synthesis; serine metabolism
Mesh:
Substances:
Year: 2018 PMID: 30017355 DOI: 10.1016/j.cmet.2018.06.009
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287